+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pet Veterinary Drugs Market

  • ID: 4769267
  • Report
  • Region: Global
  • 263 pages
  • Research Nester Pvt. Ltd
1 of 5

FEATURED COMPANIES

  • Bayer AG
  • Ceva
  • Dechra Pharmaceuticals
  • Elanco Animal Health
  • Merck Animal Health
  • Orion Corporation
  • MORE

The global Pet Veterinary Drugs Market reached USD 16,239.3 Million in 2018. Moreover, the market is expected to garner USD 21,205.2 Million by the end of 2025 by registering a CAGR of 3.9% across the globe. The global demand for Pet Veterinary Drugs is increasing due to significant growth in healthcare industry across the globe. Further, growing pet adoption and increase in pet expenditure and routine care are key growth driver for global pet veterinary drugs market over the forecast period.

North America is slated to account for a share of 38.5% by 2025 in the pet veterinary drugs market. The growth in the region can be attributed to growing pet expenditure. Re-occurrence of animal diseases is also expected to impel the growth of pet veterinary drugs market in the North America. U.S. is the prominent market driving the growth in the region. Additionally, U.S. pet veterinary drugs market reached USD 5,427 Million in 2018 and is expected to reach USD7,176.2 Million by the end of 2025, expanding at a CAGR of 4.1% over the forecast period i.e. 2019-2025. U.S. pet veterinary drugs market is expected to achieve Y-o-Y growth rate of 4.4% in 2025 as compared to previous year.

The global pet veterinary drugs market is segmented on the basis of drugs into Pharmaceuticals & Biologics and Vaccines. Among these segments, Pharmaceuticals & Biologics segment (71.4% share in 2018) occupies the largest market of pet veterinary drugs across the globe. Further, vaccines segment is anticipated to reach USD6,120.4 Million by the end of 2025 from USD4,643.1 Million in 2018. Moreover, this segment is anticipated to flourish at a CAGR of 4.1% over the forecast period. In addition Recombinant Vaccines segment of drugs is expected to achieve Y-o-Y growth rate of 4.6% in 2025 as compared to previous year.

The global pet veterinary drugs market is segmented on the basis of composition into Anti-Infectives, Anti-Inflammatory, Parasiticides, Analgesics & Sedatives and Others. Among these segments, Parasiticides segment (42.4% share in 2018) occupies the largest market of pet veterinary drugs on the basis of composition across the globe. Further, global Anti-Infectives segment is anticipated to reach USD6,791.0 Million by the end of 2025 from USD 5,179.8 Million in 2018. Moreover, this segment is anticipated to flourish at a CAGR of 4.0% over the forecast period. In addition Parasiticides segment of pet veterinary drugs under composition is expected to achieve Y-o-Y growth rate of 4.4% in 2025 as compared to previous year.

Some of the leading manufacturers in this market are Zoetis, Bayer AG, Boehringer Ingelheim International GmbH, Merck Animal Health among others.

READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bayer AG
  • Ceva
  • Dechra Pharmaceuticals
  • Elanco Animal Health
  • Merck Animal Health
  • Orion Corporation
  • MORE
1. Introduction
1.1. Market Definition
1.2. Product Overview
1.3. Market Segmentation

2. Assumptions and Acronyms

3. Research Methodology

4. Executive Summary- Global Pet Veterinary Drugs Market

5. Market Dynamics
5.1. Drivers
5.2. Restraints
5.3. Trends
5.4. Opportunities

6. Risk Analysis
6.1. Demand Risk
6.2. Supply Risk

7. Global Pet Veterinary Drugs Market Outlook
7.1. Market Size and Forecast, 2016-2025
7.1.1. By Value (USD Million)
7.1.1.1. Y-o-Y Growth (%), 2017-2025
7.2. Market Share and Forecast, 2016-2025
7.2.1. By Drugs
7.2.1.1.a. Pet Veterinary Drugs Market Share (%), By Drugs (2016, 2025F)
7.2.1.1.1. Pharmaceuticals & Biologics, Vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
7.2.1.1.1.1. Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines & Toxoid vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
7.2.1.1.b. Pet Veterinary Drugs Market Analysis, By Drugs (2016, 2025F)
7.2.1.2. Market Attractiveness Analysis, By Drugs
7.2.1.3. Market Contribution and BPS Analysis, 2016 & 2025, By Drugs
7.2.2. By Composition
7.2.2.1.2.a. Pet Veterinary Drugs Market Share (%), By Composition (2016, 2025F)
7.2.2.1.1. Anti-Infectives, Anti-Inflammatory & Parasiticides, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
7.2.2.1.2. Analgesics & Sedatives and Others, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
7.2.2.1.b. Pet Veterinary Drugs Market Analysis, By Composition (2016, 2025F)
7.2.2.2. Market Attractiveness Analysis, By Composition
7.2.2.3. Market Contribution and BPS Analysis, 2016 & 2025, By Composition
7.2.3. By Route of Administration
7.2.3.1.a. Pet Veterinary Drugs Market Share (%), By Route of Administration (2016, 2025F)
7.2.3.1.1. Oral, Parenteral & Topical, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
7.2.3.1.b. Pet Veterinary Drugs Market Analysis, By Route of Administration (2016, 2025F)
7.2.3.2. Market Attractiveness Analysis, By Route of Administration
7.2.3.3. Market Contribution and BPS Analysis, 2016 & 2025, By Route of Administration
7.2.4. By End User
7.2.4.1.a. Pet Veterinary Drugs Market Share (%), By End User (2016, 2025F)
7.2.4.1.1. Veterinary Hospitals, Veterinary Clinics & Drug Stores, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
7.2.4.1.b. Pet Veterinary Drugs Market Analysis, By End User (2016, 2025F)
7.2.4.2. Market Attractiveness Analysis, By End User
7.2.4.3. Market Contribution and BPS Analysis, 2016 & 2025, By End User
7.2.5. By Region
7.2.5.1. Pet Veterinary Drugs Market Share (%), By Region (2016,2025F)
7.2.5.1.1. North America
7.2.5.1.2. Europe
7.2.5.1.3. Asia Pacific
7.2.5.1.4. Latin America
7.2.5.1.5. Middle East and Africa

8. North America Pet Veterinary Drugs Market Outlook
8.1. Macro-Economic Indicators impacting the North America Pet Veterinary Drugs Market
8.2. Market Size and Forecast, 2016-2025
8.2.1. By Value (USD Million)
8.2.1.1. Y-o-Y Growth (%), 2017-2025
8.3. Market Share and Forecast, 2016-2025
8.3.1. By Drugs
8.3.1.1. Pet Veterinary Drugs Market Share (%), By Drugs (2016, 2025F)
8.3.1.1.1. Pharmaceuticals & Biologics, Vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
8.3.1.1.1.1. Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines & Toxoid vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
8.3.1.2. Market Attractiveness Analysis, By Drugs
8.3.1.3. Market Contribution and BPS Analysis, 2016 & 2025, By Drugs
8.3.2. By Composition
8.3.2.1. Pet Veterinary Drugs Market Share (%), By Composition (2016, 2025F)
8.3.2.1.1. Anti-Infectives, Anti-Inflammatory & Parasiticides, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
8.3.2.1.2. Analgesics & Sedatives and Others, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
8.3.2.2. Market Attractiveness Analysis, By Composition
8.3.2.3. Market Contribution and BPS Analysis, 2016 & 2025, By Composition
8.3.3. By Route of Administration
8.3.3.1. Pet Veterinary Drugs Market Share (%), By Route of Administration (2016, 2025F)
8.3.3.1.1. Oral, Parenteral & Topical, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
8.3.3.2. Market Attractiveness Analysis, By Route of Administration
8.3.3.3. Market Contribution and BPS Analysis, 2016 & 2025, By Route of Administration
8.3.4. By End User
8.3.4.1. Pet Veterinary Drugs Market Share (%), By End User (2016, 2025F)
8.3.4.1.1. Veterinary Hospitals, Veterinary Clinics & Drug Stores, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
8.3.4.2. Market Attractiveness Analysis, By End User
8.3.4.3. Market Contribution and BPS Analysis, 2016 & 2025, By End User
8.3.5. By Country
8.3.5.1. Pet Veterinary Drugs Market Share (%), By Country (2016,2025F)
8.3.5.1.1. United States & Canada, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025

9. Europe Pet Veterinary Drugs Market Outlook
9.1. Macro-Economic Indicators impacting the Europe Pet Veterinary Drugs Market
9.2. Market Size and Forecast, 2016-2025
9.2.1. By Value (USD Million)
9.2.1.1. Y-o-Y Growth (%), 2017-2025
9.3. Market Share and Forecast, 2016-2025
9.3.1. By Drugs
9.3.1.1. Pet Veterinary Drugs Market Share (%), By Drugs (2016, 2025F)
9.3.1.1.1. Pharmaceuticals & Biologics, Vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
9.3.1.1.1.1. Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines & Toxoid vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
9.3.1.2. Market Attractiveness Analysis, By Drugs
9.3.1.3. Market Contribution and BPS Analysis, 2016 & 2025, By Drugs
9.3.2. By Composition
9.3.2.1. Pet Veterinary Drugs Market Share (%), By Composition (2016, 2025F)
9.3.2.1.1. Anti-Infectives, Anti-Inflammatory & Parasiticides, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
9.3.2.1.2. Analgesics & Sedatives and Others, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
9.3.2.2. Market Attractiveness Analysis, By Composition
9.3.2.3. Market Contribution and BPS Analysis, 2016 & 2025, By Composition
9.3.3. By Route of Administration
9.3.3.1. Pet Veterinary Drugs Market Share (%), By Route of Administration (2016, 2025F)
9.3.3.1.1. Oral, Parenteral & Topical, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
9.3.3.2. Market Attractiveness Analysis, By Route of Administration
9.3.3.3. Market Contribution and BPS Analysis, 2016 & 2025, By Route of Administration
9.3.4. By End User
9.3.4.1. Pet Veterinary Drugs Market Share (%), By End User (2016, 2025F)
9.3.4.1.1. Veterinary Hospitals, Veterinary Clinics & Drug Stores, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
9.3.4.2. Market Attractiveness Analysis, By End User
9.3.4.3. Market Contribution and BPS Analysis, 2016 & 2025, By End User
9.3.5. By Country
9.3.5.1. Pet Veterinary Drugs Market Share (%), By Country (2016,2025F)
9.3.5.1.1. Germany, United Kingdom & France, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
9.3.5.1.2. Italy, Spain & Russia, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
9.3.5.1.3. Poland, BENELUX & rest of Europe, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025

10. Asia Pacific Pet Veterinary Drugs Market Outlook
10.1. Macro-Economic Indicators impacting the Asia Pacific Pet Veterinary Drugs Market
10.2. Market Size and Forecast, 2016-2025
10.2.1. By Value (USD Million)
10.2.1.1. Y-o-Y Growth (%), 2017-2025
10.3. Market Share and Forecast, 2016-2025
10.3.1. By Drugs
10.3.1.1. Pet Veterinary Drugs Market Share (%), By Drugs (2016, 2025F)
10.3.1.1.1. Pharmaceuticals & Biologics, Vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
10.3.1.1.1.1. Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines & Toxoid vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
10.3.1.2. Market Attractiveness Analysis, By Drugs
10.3.1.3. Market Contribution and BPS Analysis, 2016 & 2025, By Drugs
10.3.2. By Composition
10.3.2.1. Pet Veterinary Drugs Market Share (%), By Composition (2016, 2025F)
10.3.2.1.1. Anti-Infectives, Anti-Inflammatory & Parasiticides, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
10.3.2.1.2. Analgesics & Sedatives and Others, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
10.3.2.2. Market Attractiveness Analysis, By Composition
10.3.2.3. Market Contribution and BPS Analysis, 2016 & 2025, By Composition
10.3.3. By Route of Administration
10.3.3.1. Pet Veterinary Drugs Market Share (%), By Route of Administration (2016, 2025F)
10.3.3.1.1. Oral, Parenteral & Topical, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
10.3.3.2. Market Attractiveness Analysis, By Route of Administration
10.3.3.3. Market Contribution and BPS Analysis, 2016 & 2025, By Route of Administration
10.3.4. By End User
10.3.4.1. Pet Veterinary Drugs Market Share (%), By End User (2016, 2025F)
10.3.4.1.1. Veterinary Hospitals, Veterinary Clinics & Drug Stores, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
10.3.4.2. Market Attractiveness Analysis, By End User
10.3.4.3. Market Contribution and BPS Analysis, 2016 & 2025, By End User
10.3.5. By Country
10.3.5.1. Pet Veterinary Drugs Market Share (%), By Country (2016,2025F)
10.3.5.1.1. India, China and Japan, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
10.3.5.1.2. Australia, New Zealand & Rest of Asia Pacific 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025

11. Latin America Pet Veterinary Drugs Market Outlook
11.1. Macro-Economic Indicators impacting the Latin America Pet Veterinary Drugs Market
11.2. Market Size and Forecast, 2016-2025
11.2.1. By Value (USD Million)
11.2.1.1. Y-o-Y Growth (%), 2017-2025
11.3. Market Share and Forecast, 2016-2025
11.3.1. By Drugs
11.3.1.1. Pet Veterinary Drugs Market Share (%), By Drugs (2016, 2025F)
11.3.1.1.1. Pharmaceuticals & Biologics, Vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
11.3.1.1.1.1. Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines & Toxoid vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
11.3.1.2. Market Attractiveness Analysis, By Drugs
11.3.1.3. Market Contribution and BPS Analysis, 2016 & 2025, By Drugs
11.3.2. By Composition
11.3.2.1. Pet Veterinary Drugs Market Share (%), By Composition (2016, 2025F)
11.3.2.1.1. Anti-Infectives, Anti-Inflammatory & Parasiticides, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
11.3.2.1.2. Analgesics & Sedatives and Others, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
11.3.2.2. Market Attractiveness Analysis, By Composition
11.3.2.3. Market Contribution and BPS Analysis, 2016 & 2025, By Composition
11.3.3. By Route of Administration
11.3.3.1. Pet Veterinary Drugs Market Share (%), By Route of Administration (2016, 2025F)
11.3.3.1.1. Oral, Parenteral & Topical, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
11.3.3.2. Market Attractiveness Analysis, By Route of Administration
11.3.3.3. Market Contribution and BPS Analysis, 2016 & 2025, By Route of Administration
11.3.4. By End User
11.3.4.1. Pet Veterinary Drugs Market Share (%), By End User (2016, 2025F)
11.3.4.1.1. Veterinary Hospitals, Veterinary Clinics & Drug Stores, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
11.3.4.2. Market Attractiveness Analysis, By End User
11.3.4.3. Market Contribution and BPS Analysis, 2016 & 2025, By End User
11.3.5. By Country
11.3.5.1. Pet Veterinary Drugs Market Share (%), By Country (2016,2025F)
11.3.5.1.1. Brazil, Mexico & Rest of Latin America, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025

12. Middle East and Africa Pet Veterinary Drugs Market Outlook
12.1. Macro-Economic Indicators impacting the Middle East and Africa Pet Veterinary Drugs Market
12.2. Market Size and Forecast, 2016-2025
12.2.1. By Value (USD Million)
12.2.1.1. Y-o-Y Growth (%), 2017-2025
12.3. Market Share and Forecast, 2016-2025
12.3.1. By Drugs
12.3.1.1. Pet Veterinary Drugs Market Share (%), By Drugs (2016, 2025F)
12.3.1.1.1. Pharmaceuticals & Biologics, Vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
12.3.1.1.1.1. Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines & Toxoid vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
12.3.1.2. Market Attractiveness Analysis, By Drugs
12.3.1.3. Market Contribution and BPS Analysis, 2016 & 2025, By Drugs
12.3.2. By Composition
12.3.2.1. Pet Veterinary Drugs Market Share (%), By Composition (2016, 2025F)
12.3.2.1.1. Anti-Infectives, Anti-Inflammatory & Parasiticides, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
12.3.2.1.2. Analgesics & Sedatives and Others, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
12.3.2.2. Market Attractiveness Analysis, By Composition
12.3.2.3. Market Contribution and BPS Analysis, 2016 & 2025, By Composition
12.3.3. By Route of Administration
12.3.3.1. Pet Veterinary Drugs Market Share (%), By Route of Administration (2016, 2025F)
12.3.3.1.1. Oral, Parenteral & Topical, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
12.3.3.2. Market Attractiveness Analysis, By Route of Administration
12.3.3.3. Market Contribution and BPS Analysis, 2016 & 2025, By Route of Administration
12.3.4. By End User
12.3.4.1. Pet Veterinary Drugs Market Share (%), By End User (2016, 2025F)
12.3.4.1.1. Veterinary Hospitals, Veterinary Clinics & Drug Stores, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
12.3.4.2. Market Attractiveness Analysis, By End User
12.3.4.3. Market Contribution and BPS Analysis, 2016 & 2025, By End User
12.3.5. By Country
12.3.5.1. Pet Veterinary Drugs Market Share (%), By Country (2016,2025F)
12.3.5.1.1. GCC & North Africa, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
12.3.5.1.2. South Africa & Rest of Middle East & Africa, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025

13. Policies & Regulations

14. Porter’s Five Force Model

15. Competitive Landscape
15.1. Competitive Positioning of Major Players in Global Pet Veterinary Drugs Market
15.2. Company Profiles
15.2.1. Boehringer Ingelheim International GmbH
15.2.1.1. Company Overview
15.2.1.2. Business Strategy
15.2.1.2.1. Growth Expansion Strategy
15.2.1.2.2. Distribution Channel Strategy
15.2.1.2.3. Product Strategy
15.2.1.3. Key Product Offerings
15.2.1.4. Financial Performance
15.2.1.5. Key Performance Indicators
15.2.1.6. Risk Analysis
15.2.1.7. Recent Development
15.2.1.8. Regional Presence
15.2.1.9. SWOT Analysis
15.2.2. Zoetis Animal Healthcare
15.2.3. Bayer AG
15.2.4. Merck Animal Health
15.2.5. Elanco Animal Health Inc.
15.2.6. Virbac Group
15.2.7. Ceva
15.2.8. Dechra Pharmaceuticals Plc
15.2.9. Vetoquinol
15.2.10. Orion Corporation
15.2.11. Other Prominent Players
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Boehringer Ingelheim International GmbH
  • Zoetis Animal Healthcare
  • Bayer AG
  • Merck Animal Health
  • Elanco Animal Health
  • Virbac Group
  • Ceva
  • Dechra Pharmaceuticals
  • Vetoquinol
  • Orion Corporation
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

6 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4769267
Adroll
adroll